Vaccines and Toxoids 2017 Changes (October 2016)

Why This Topic Matters

Immunization coding changes can affect code selection, descriptor interpretation, and awareness of product-status updates. This article helps readers understand which vaccine-related CPT changes were introduced for 2017 and where the AMA directs users to monitor ongoing updates.

Article Sections

1. October 2016 pages 6-7

   Introductory overview of the 2017 vaccines and toxoids changes in CPT. Summarizes the broad categories of updates covered in the article.

2. Cell Culture-Derived Quadrivalent Vaccines

   Discusses the cell culture-derived influenza vaccine product updates and related CPT descriptor revisions. Also notes background information about the product family and AMA/CPT website update process.

3. Revisions to the Influenza Vaccine Code Structure

   Covers the restructuring of influenza vaccine product code descriptors in CPT 2017. Provides context on how the product groupings were organized in the updated code set.

4. Updated ACIP Abbreviation

   Addresses an update to a vaccine-related abbreviation in the meningococcal conjugate vaccine descriptor. Includes related guidance about abbreviation usage and supporting references.

5. FDA Vaccine Licensure Update

   Summarizes CPT vaccine product codes affected by changes in FDA approval status. Notes how the article frames those status updates and where users are directed for current information.